Caredx Inc Stock Investor Sentiment

CDNA Stock  USD 19.27  0.37  1.96%   
About 66 percent of all Caredx's investors are curious in acquiring. The analysis of the overall investor sentiment regarding Caredx Inc suggests that a large number of traders are confidant. The current market sentiment, together with Caredx's historical and current headlines, can help investors time the market. In addition, many technical investors use Caredx Inc stock news signals to limit their universe of possible portfolio assets.

Comfort Level 66

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Caredx's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Caredx Inc.

Caredx Historical Sentiment

Although Caredx's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Caredx, such as negative comments on social media and news outlets, may cause fear in the market and push Caredx's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Caredx.
  

Caredx Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Caredx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Caredx Inc Historical Investor Sentiment

Investor biases related to Caredx's public news can be used to forecast risks associated with an investment in Caredx. The trend in average sentiment can be used to explain how an investor holding Caredx can time the market purely based on public headlines and social activities around Caredx Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Caredx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Caredx and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Caredx news discussions. The higher the estimate score, the more favorable the investor's outlook on Caredx.
over two weeks ago at gurufocus.com         
CareDx Inc Wins Legal Battle as Court Overturns Patent Verdict
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
CareDx Inc Q4 2024 Everything You Need To Know Ahead Of Earnings
Yahoo News
over two weeks ago at kalkinemedia.com         
How Are Institutional Holdings in CareDx Changing
news
over three weeks ago at gurufocus.com         
CareDx Inc Under Investigation for Potential Securities Law Violations
Gurufocus Stories at Macroaxis
over three weeks ago at businesswire.com         
CareDxAlloSeq cfDNA
businesswire News
over three weeks ago at businesswire.com         
CareDx anuncia un estudio que demuestra la alta precisin de AlloSeq cfDNA en la deteccin del rechazo...
businesswire News
over three weeks ago at gurufocus.com         
CareDx Inc Announces Positive Study Results for AlloSeq cfDNA in Detecting Kidney ...
Gurufocus Stories at Macroaxis
over three weeks ago at businesswire.com         
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
businesswire News
over three weeks ago at businesswire.com         
CareDx publie une tude confirmant la grande prcision dAlloSeq cfDNA dans la dtection du rejet chez l...
businesswire News
over three weeks ago at businesswire.com         
CareDx publie une tude confirmant la grande prcision dAlloSeq cfDNA dans la dtection du rejet chez l...
businesswire News
over three weeks ago at businesswire.com         
CareDx anuncia estudo que mostra que o cfDNA AlloSeq altamente preciso na deteco de rejeio em pacien...
businesswire News
over three weeks ago at businesswire.com         
Riassunto CareDx annuncia uno studio che dimostra lelevata precisione di AlloSeq cfDNA nel rilevamen...
businesswire News
over three weeks ago at businesswire.com         
CareDx gibt Studie bekannt, die zeigt, dass AlloSeq cfDNA bei der Erkennung von Abstoungsreaktionen ...
businesswire News
over three weeks ago at zacks.com         
Pediatrix Medical Group Surpasses Q4 Earnings and Revenue Estimates
zacks News
over three weeks ago at businesswire.com         
Samenvatting CareDx maakt een studie bekend die aantoont dat AlloSeq cfDNA zeer nauwkeurig is om afs...
businesswire News
Far too much social signal, news, headlines, and media speculation about Caredx that are available to investors today. That information is available publicly through Caredx media outlets and privately through word of mouth or via Caredx internal channels. However, regardless of the origin, that massive amount of Caredx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Caredx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Caredx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Caredx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Caredx alpha.

Caredx Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
CareDx Inc Shares Gap Down to 21.13 on Jan 16
01/16/2025
2
Disposition of 1917 shares by Jeffrey Novack of Caredx at 26.0 subject to Rule 16b-3
01/24/2025
3
Disposition of 2048 shares by Jeffrey Novack of Caredx at 23.32 subject to Rule 16b-3
02/03/2025
4
Disposition of 3512 shares by Jeffrey Novack of Caredx at 23.2999 subject to Rule 16b-3
02/04/2025
5
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
02/20/2025
6
CareDx Inc Q4 2024 Everything You Need To Know Ahead Of Earnings
02/25/2025
7
CareDx Q4 Earnings Snapshot
02/26/2025
8
CareDxs Overweight Rating Reaffirmed at Stephens
02/27/2025
9
CareDx Full Year 2024 Earnings EPS Beats Expectations
02/28/2025
10
CareDx Inc Under Investigation Legal Challenges and Financial Struggles
03/04/2025
11
Acquisition by Peter Maag of 13281 shares of Caredx at 5.27 subject to Rule 16b-3
03/05/2025
12
Disposition of 1905 shares by Jeffrey Novack of Caredx at 22.64 subject to Rule 16b-3
03/06/2025
13
Statutory Earnings May Not Be The Best Way To Understand CareDxs True Position
03/07/2025
14
Disposition of 20000 shares by Bickerstaff George of Caredx at 18.3551 subject to Rule 16b-3
03/10/2025
15
Why CareDxs Earnings Are Weaker Than They Seem
03/11/2025
16
Disposition of 7371 shares by Abhishek Jain of Caredx at 9.18 subject to Rule 16b-3
03/13/2025

Complementary Tools for Caredx Stock analysis

When running Caredx's price analysis, check to measure Caredx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caredx is operating at the current time. Most of Caredx's value examination focuses on studying past and present price action to predict the probability of Caredx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caredx's price. Additionally, you may evaluate how the addition of Caredx to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Transaction History
View history of all your transactions and understand their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance